Study type: Human research · Status: Verified against declared source

Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke.

BMC neurology · 2016

Study scale: Stroke severity at T0 was recorded using the NIHSS [13] in all enrolled patients.

Abstract only: Open source record

Product or molecular entity relationships

Cerebrolysin: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Cerebrolysin is a neuropeptide preparation with neuroprotective and neurorestorative effects.

Methods

This phase IV trial was designed as a prospective, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Scale or participants

Stroke severity at T0 was recorded using the NIHSS [13] in all enrolled patients.

Key findings

Cerebrolysin is a neuropeptide preparation with neuroprotective and neurorestorative effects.

Limitations and uncertainty

Both groups demonstrated significant improvement in motor function (p < 0.05); however, no significant difference was found between the two groups.

Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.